Upstream Manufacturing Webinars
-
Overcoming Cloning Inefficiencies To Accelerate New Protein Therapeutics
10/24/2023
Watch as a scientist from Advanced Instruments demonstrates how the InstiGRO™ CHO cell culture supplement can be used to enhance clonal outgrowth during single cell seeding experiments.
-
MAVEN™: Monitor And Control Both Glucose And Lactate In Real-Time
10/4/2023
Get faster process insights and dynamic control of substrate feeding without the loss of bioreactor or fermenter volume.
-
Monitoring Multiple Bioprocess Parameters Right Out Of The Box
10/4/2023
There’s no need to deal with complex empirical calibration models, reagents, or unreliable auto-sampling systems to implement in-line bioreactor monitoring.
-
Raman-Based Monitoring Of Multiple Critical Parameters
10/4/2023
Powered by Raman spectroscopy and a purpose-built de novo model, this platform performs simultaneous real-time measurements of multiple key process parameters in mammalian cell cultures.
-
The Technology Debate: Single-Use vs. Stainless Steel
10/4/2023
In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.
-
Capabilities And Opportunities Of Innovative Cell Processing System In CGT
8/15/2023
Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.
-
Maintaining mAb Viability After The Exponential Growth Phase
8/9/2023
During the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline, Bayer’s Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., graciously answered dozens of audience questions. Here, he offers advice on maintaining cell viability at a given target value after the exponential growth phase.
-
Multi-Specific Antibody Development: What Challenges The Need For Speed?
8/9/2023
In this segment of the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline, Bayer’s Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., addresses why the industry is pursuing faster, more cost-effective multi-specific antibody development and some of the major challenges standing in the way of efficiency.
-
Vaccine Journey: Bench To Market
7/19/2023
Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.
-
Advancements In Aseptic Connection Technologies
7/17/2023
Expand your knowledge on the latest innovation in the sterile connector space including the new 1.5” flow path connector, disconnection solution, and more.